Savitha M. Rao

Array ( [id] => 8336128 [patent_doc_number] => 20120202836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/501274 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4164 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427706 [patent_doc_number] => 08703781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors' [patent_app_type] => utility [patent_app_number] => 13/499779 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21210 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273635 [patent_doc_number] => 08637567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid' [patent_app_type] => utility [patent_app_number] => 12/903844 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 27 [patent_no_of_words] => 15797 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12903844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195439 [patent_doc_number] => 20110027193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/903120 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10961 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027193.pdf [firstpage_image] =>[orig_patent_app_number] => 12903120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336131 [patent_doc_number] => 20120202837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'SPIROCYCLIC PIPERIDINE DERIVATIVES USEFUL AS RENIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/501401 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18758 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324476 [patent_doc_number] => 20120196886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'COMBINATION' [patent_app_type] => utility [patent_app_number] => 13/500241 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17538 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626618 [patent_doc_number] => 08796298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/500698 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16903 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148821 [patent_doc_number] => 20110020416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Encapsulated Fragrance Materials and Methods for Making Same' [patent_app_type] => utility [patent_app_number] => 12/894310 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18472 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020416.pdf [firstpage_image] =>[orig_patent_app_number] => 12894310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6120967 [patent_doc_number] => 20110077224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'LINOLEIC PHOSPHOLIPIDS AND USES THEREOF FOR INHIBITING INFLAMMATORY AND NEURODEGENERATIVE PROCESSES' [patent_app_type] => utility [patent_app_number] => 12/892671 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7637 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077224.pdf [firstpage_image] =>[orig_patent_app_number] => 12892671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128010 [patent_doc_number] => 20110086869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'METHODS FOR TREATING VIRAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/890042 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20051 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086869.pdf [firstpage_image] =>[orig_patent_app_number] => 12890042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8006129 [patent_doc_number] => 08084465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Derivatives of pryidone and use thereof' [patent_app_type] => utility [patent_app_number] => 12/885343 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5062 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084465.pdf [firstpage_image] =>[orig_patent_app_number] => 12885343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644481 [patent_doc_number] => 08022087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Derivatives of pyridone and use thereof' [patent_app_type] => utility [patent_app_number] => 12/885353 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5060 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022087.pdf [firstpage_image] =>[orig_patent_app_number] => 12885353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214272 [patent_doc_number] => 20110136844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'METHODS FOR INHIBITING DYRK1A TO TREAT CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/884480 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9707 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136844.pdf [firstpage_image] =>[orig_patent_app_number] => 12884480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137141 [patent_doc_number] => 20110009490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'PREPARATION OF THE FORMAURINDIKARBOXYL ACID BASE AND ITS DERIVATIONS AND USE' [patent_app_type] => utility [patent_app_number] => 12/879483 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1248 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009490.pdf [firstpage_image] =>[orig_patent_app_number] => 12879483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359648 [patent_doc_number] => 20120214798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Novel Ethanediamone Hepcidine Antagonists' [patent_app_type] => utility [patent_app_number] => 13/394201 [patent_app_country] => US [patent_app_date] => 2010-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 43017 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343771 [patent_doc_number] => 20100330131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE' [patent_app_type] => utility [patent_app_number] => 12/875876 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 41670 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330131.pdf [firstpage_image] =>[orig_patent_app_number] => 12875876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167914 [patent_doc_number] => 20110196026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY' [patent_app_type] => utility [patent_app_number] => 12/874965 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26993 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196026.pdf [firstpage_image] =>[orig_patent_app_number] => 12874965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253127 [patent_doc_number] => 20120157451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/393069 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25103 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157451.pdf [firstpage_image] =>[orig_patent_app_number] => 13393069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944930 [patent_doc_number] => 20110105550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'FORMS OF RIFAXIMIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/868322 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 21946 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105550.pdf [firstpage_image] =>[orig_patent_app_number] => 12868322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9469019 [patent_doc_number] => 08722650 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-05-13 [patent_title] => 'Extended-release minocycline dosage forms' [patent_app_type] => utility [patent_app_number] => 12/861424 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5479 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12861424 [rel_patent_id] =>[rel_patent_doc_number] =>)